Cases we'll be looking at concern ingestion of Vioxx for 18 months or more by patients with limited heart risk factors.
Merck didn't ask for any delays and is ready to defend any of these cases whenever they are scheduled.
We intend to try these cases one by one and that is exactly what we are doing.
For a relatively small set of cases that involve patients who used Vioxx for over 18 months, we will take a close look.